Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency).

Mayo Clinic proceedings·2026
Same author

Lower <i>SYNJ2BP</i> Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis.

Cancer genomics & proteomics·2025
Same author

Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma.

Cancer genomics & proteomics·2025
Same author

Individualized Surgical Management for Thyroglossal Duct Cyst-Papillary Thyroid Carcinoma: A Case Series.

The Laryngoscope·2025
Same author

Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry.

Human pathology·2025
Same author

Challenges and Opportunities in Cytopathology Artificial Intelligence.

Bioengineering (Basel, Switzerland)·2025
Same journal

Patient Safety Monitoring in International Laboratories.

MLO: medical laboratory observer·2026
Same journal

Taking issue with some OIG recommendations.

MLO: medical laboratory observer·2018
Same journal

PCR then and now Improvements to technologies expand clinical utilization.

MLO: medical laboratory observer·2018
Same journal

Outsourcing vs. insourcing Which strategy is the better way for labs to support their larger institution?

MLO: medical laboratory observer·2018
Same journal

The autoimmune response and neuropsychiatric disorders.

MLO: medical laboratory observer·2018
Same journal

Pathogen discovery through deep sequencing.

MLO: medical laboratory observer·2018
See all related articles

Related Experiment Video

Updated: May 30, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

HPV: a look into new methods for high-risk testing

Jordan P Reynolds1

  • 1Cleveland Clinic, Cleveland, OH, USA.

MLO: Medical Laboratory Observer
|August 12, 2011
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: May 30, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012